JPH04293494A - Production of fructose-containing oligosaccharide or glycoside - Google Patents
Production of fructose-containing oligosaccharide or glycosideInfo
- Publication number
- JPH04293494A JPH04293494A JP3081337A JP8133791A JPH04293494A JP H04293494 A JPH04293494 A JP H04293494A JP 3081337 A JP3081337 A JP 3081337A JP 8133791 A JP8133791 A JP 8133791A JP H04293494 A JPH04293494 A JP H04293494A
- Authority
- JP
- Japan
- Prior art keywords
- fructose
- sucrose
- invertase
- glycoside
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 title claims abstract description 38
- 229930091371 Fructose Natural products 0.000 title claims abstract description 37
- 239000005715 Fructose Substances 0.000 title claims abstract description 37
- 229920001542 oligosaccharide Polymers 0.000 title claims abstract description 26
- 150000002482 oligosaccharides Chemical class 0.000 title claims abstract description 26
- 229930182470 glycoside Natural products 0.000 title claims abstract description 25
- 150000002338 glycosides Chemical class 0.000 title claims abstract description 25
- 238000004519 manufacturing process Methods 0.000 title claims description 10
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims abstract description 31
- 229930006000 Sucrose Natural products 0.000 claims abstract description 31
- 239000005720 sucrose Substances 0.000 claims abstract description 31
- 108010051210 beta-Fructofuranosidase Proteins 0.000 claims abstract description 29
- 235000011073 invertase Nutrition 0.000 claims abstract description 29
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 27
- 239000001573 invertase Substances 0.000 claims abstract description 21
- 230000002950 deficient Effects 0.000 claims abstract description 19
- FVVCFHXLWDDRHG-UPLOTWCNSA-N (2s,3r,4s,5r,6r)-2-[(2r,3s,4r,5r,6r)-6-[(2s,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)[C@@H](CO)O1 FVVCFHXLWDDRHG-UPLOTWCNSA-N 0.000 claims abstract description 9
- 241000186073 Arthrobacter sp. Species 0.000 claims abstract description 7
- VMRGPCWYQLQNRB-ZHRVIQQSSA-N [(2S,3R,4S,5S,6R)-6-[[(2R,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4,5-trihydroxyoxan-2-yl] (1R,4S,5R,9S,10R,13S)-13-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.01,10.04,9]hexadecane-5-carboxylate Chemical compound C[C@@]12CCC[C@](C)([C@H]1CC[C@@]13CC(=C)[C@@](C1)(CC[C@@H]23)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C(=O)O[C@@H]1O[C@H](CO[C@]2(CO)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@H](O)[C@H]1O VMRGPCWYQLQNRB-ZHRVIQQSSA-N 0.000 claims abstract description 3
- 108010042889 Inulosucrase Proteins 0.000 claims description 16
- 244000063299 Bacillus subtilis Species 0.000 claims description 4
- 235000014469 Bacillus subtilis Nutrition 0.000 claims description 4
- 108010036940 Levansucrase Proteins 0.000 claims description 4
- 244000005700 microbiome Species 0.000 claims description 4
- UWESPNLLJKPBBH-JJNZJHQXSA-N (2s,3r,4s,5s,6r)-2-[(2s,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]-6-(hydroxymethyl)-2-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxane-3,4,5-triol Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@]1(CO)[C@@]1(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 UWESPNLLJKPBBH-JJNZJHQXSA-N 0.000 claims description 3
- ODEHMIGXGLNAKK-OESPXIITSA-N 6-kestotriose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@@H]1[C@@H](O)[C@H](O)[C@](CO)(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O1 ODEHMIGXGLNAKK-OESPXIITSA-N 0.000 claims description 2
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 claims description 2
- YWPVROCHNBYFTP-UHFFFAOYSA-N Rubusoside Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C2)CC(=C)C21OC1OC(CO)C(O)C(O)C1O YWPVROCHNBYFTP-UHFFFAOYSA-N 0.000 claims description 2
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 claims description 2
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 claims description 2
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 claims description 2
- 229930188195 rebaudioside Natural products 0.000 claims description 2
- YWPVROCHNBYFTP-OSHKXICASA-N rubusoside Chemical compound O([C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YWPVROCHNBYFTP-OSHKXICASA-N 0.000 claims description 2
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 claims description 2
- 241000193830 Bacillus <bacterium> Species 0.000 claims 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 abstract description 15
- 239000008101 lactose Substances 0.000 abstract description 15
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract description 11
- CHUGKEQJSLOLHL-UHFFFAOYSA-N 2,2-Bis(bromomethyl)propane-1,3-diol Chemical compound OCC(CO)(CBr)CBr CHUGKEQJSLOLHL-UHFFFAOYSA-N 0.000 abstract description 7
- 239000005909 Kieselgur Substances 0.000 abstract description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 abstract description 5
- 238000001914 filtration Methods 0.000 abstract description 5
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 abstract description 4
- 239000003456 ion exchange resin Substances 0.000 abstract description 4
- 229920003303 ion-exchange polymer Polymers 0.000 abstract description 4
- 235000013305 food Nutrition 0.000 abstract description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 3
- 239000003814 drug Substances 0.000 abstract description 2
- 239000007921 spray Substances 0.000 abstract description 2
- 102000004357 Transferases Human genes 0.000 abstract 2
- 108090000992 Transferases Proteins 0.000 abstract 2
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 239000000706 filtrate Substances 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 description 23
- 108090000790 Enzymes Proteins 0.000 description 22
- 102000004190 Enzymes Human genes 0.000 description 22
- 239000000203 mixture Substances 0.000 description 11
- 239000000047 product Substances 0.000 description 11
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 8
- 239000008103 glucose Substances 0.000 description 8
- 239000000843 powder Substances 0.000 description 8
- 239000000758 substrate Substances 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 238000000034 method Methods 0.000 description 6
- 150000002772 monosaccharides Chemical class 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 5
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 4
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 4
- 238000006911 enzymatic reaction Methods 0.000 description 4
- 229930182830 galactose Natural products 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000008399 tap water Substances 0.000 description 3
- 235000020679 tap water Nutrition 0.000 description 3
- 241000228245 Aspergillus niger Species 0.000 description 2
- 241000186000 Bifidobacterium Species 0.000 description 2
- 241000228143 Penicillium Species 0.000 description 2
- 230000000170 anti-cariogenic effect Effects 0.000 description 2
- 239000003102 growth factor Substances 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000006276 transfer reaction Methods 0.000 description 2
- PVXPPJIGRGXGCY-DJHAAKORSA-N 6-O-alpha-D-glucopyranosyl-alpha-D-fructofuranose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@](O)(CO)O1 PVXPPJIGRGXGCY-DJHAAKORSA-N 0.000 description 1
- 241001655328 Bifidobacteriales Species 0.000 description 1
- 241000985530 Penicillium glabrum Species 0.000 description 1
- 241000985513 Penicillium oxalicum Species 0.000 description 1
- 241000228168 Penicillium sp. Species 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 1
- 229940107187 fructooligosaccharide Drugs 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000012263 liquid product Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- -1 α-glucosyl stevioside Chemical compound 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/12—Disaccharides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/18—Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/44—Preparation of O-glycosides, e.g. glucosides
Abstract
Description
【0001】0001
【産業上の利用分野】本発明は、フラクトース含有オリ
ゴ糖または配糖体の製造方法に関し、詳しくは低コスト
で効率よくフラクトース含有オリゴ糖または配糖体を工
業的に製造する方法に関する。TECHNICAL FIELD The present invention relates to a method for producing fructose-containing oligosaccharides or glycosides, and more particularly to a method for industrially producing fructose-containing oligosaccharides or glycosides efficiently and at low cost.
【0002】0002
【従来の技術および発明が解決しようとする課題】近年
、健康志向の増大に伴い、グルコシル基あるいはフラク
トシル基転移酵素を用いた種々の生理活性を有するオリ
ゴ糖や有用配糖体の合成等の研究が盛んに行われている
。カップリングシュガー(登録商標),フラクトオリゴ
糖,パラチノース,α─グルコシルステビオサイドなど
が虫歯にならない、またビフィズス菌増殖因子等の性質
を持つものとして実用化された例である。[Prior Art and Problems to be Solved by the Invention] In recent years, with the increase in health consciousness, research has been conducted on the synthesis of oligosaccharides and useful glycosides with various physiological activities using glucosyl groups or fructosyl transferases. is being actively carried out. Coupling Sugar (registered trademark), fructooligosaccharide, palatinose, α-glucosyl stevioside, etc. are examples of products that have been put to practical use because they do not cause dental caries and have properties such as bifidobacteria growth factors.
【0003】現在、フラクトシル基転移酵素としてはバ
チルス・ズブチリス(Bacillus subtil
is) の生産するレバンシュクラーゼおよびアスペル
ギルス・ニガー(Aspergillus niger
),ペニシリウム・オキザリクム(Penicilli
um oxalicum), ペニシリウム・フリクエ
ンタンス(Penicillium frequent
ans),ペニシリウム・エスピー(Penicill
ium sp.) K25などのかびが生産するβ─フ
ラクトフラノシダーゼ、アルスロバクター・エスピー(
Arthrobacter sp.)K─1の生産する
β─フラクトフラノシダーゼが知られている。[0003]Currently, Bacillus subtilis is used as a fructosyltransferase.
is) and levansucrase produced by Aspergillus niger.
), Penicillium
um oxalicum), Penicillium frequency
ans), Penicillium sp.
ium sp. ) β-Fructofuranosidase produced by molds such as K25, Arthrobacter sp.
Arthrobacter sp. ) β-fructofuranosidase produced by K-1 is known.
【0004】これらの酵素で合成されるキシロシルフラ
クトシド,イソマルトシルフラクトシドは抗う蝕性の性
質を有しており、さらにフラクトオリゴ糖,ガラクトシ
ルフラクトシド,ラクトシルフラクトシドはビフィズス
菌増殖因子としての活性を有している。そのため、医薬
品および食品分野での幅広い用途が期待されている。ラ
クトシルフラクトシドの構造を図1に示す。[0004] Xylosylfructoside and isomaltosylfructoside synthesized by these enzymes have anti-cariogenic properties, and fructooligosaccharides, galactosylfructoside and lactosylfructoside are also used as Bifidobacteria growth factors. It has the activity of Therefore, it is expected to have a wide range of applications in the pharmaceutical and food fields. The structure of lactosyl fructoside is shown in Figure 1.
【0005】しかし、上記酵素を用いたオリゴ糖合成反
応は、生成物阻害によって反応が平衡に達してしまうた
め、目的とする物質、例えばラクトシルフラクトシドは
反応固形分中30%程度しか得られない。さらに、この
30%程度のラクトシルフラクトシドを含む反応液はど
のような乾燥法を用いても粉末にできないという欠点を
有する。[0005] However, in the oligosaccharide synthesis reaction using the above enzyme, the reaction reaches equilibrium due to product inhibition, so that only about 30% of the target substance, such as lactosyl fructoside, is obtained in the reaction solid content. do not have. Furthermore, this reaction solution containing about 30% of lactosyl fructoside has the disadvantage that it cannot be made into powder no matter what drying method is used.
【0006】また、インベルターゼ活性を持つ酵母を用
いてフラクトース含有オリゴ糖または配糖体を製造する
方法もあるが、この方法では該酵母がフラクトース含有
オリゴ糖または配糖体を受容体とフラクトースに分解し
てしまうため好ましくない。そこで、単糖を除去する方
法として、酵母の代わりに単糖のみを除く限外ろ過膜を
用いることは可能であるが、この方法は未だ研究段階で
あり、受容体が単糖の場合には応用できないという欠点
がある。[0006] There is also a method for producing fructose-containing oligosaccharides or glycosides using yeast with invertase activity, but in this method, the yeast decomposes the fructose-containing oligosaccharides or glycosides into receptors and fructose. This is not desirable because it causes Therefore, as a method for removing monosaccharides, it is possible to use an ultrafiltration membrane that removes only monosaccharides instead of yeast, but this method is still in the research stage, and if the receptor is a monosaccharide, The drawback is that it cannot be applied.
【0007】[0007]
【課題を解決するための手段】そこで、本発明者らはこ
のような実情を考慮し、効率のよい実用的なフラクトー
ス含有オリゴ糖または配糖体の製造方法を確立すべく研
究を重ねた結果、受容体の存在下、スクロースにフラク
トシル基転移酵素を作用させ、生成するグルコースをイ
ンベルターゼ欠損酵母によって資化すれば、フラクトー
ス含有オリゴ糖または配糖体を効率よく製造することが
できることを見出し、本発明を完成したのである。[Means for Solving the Problems] Therefore, the present inventors have conducted extensive research in order to establish an efficient and practical method for producing fructose-containing oligosaccharides or glycosides, taking these circumstances into consideration. discovered that fructose-containing oligosaccharides or glycosides can be efficiently produced by allowing fructosyltransferase to act on sucrose in the presence of a receptor, and the resulting glucose is assimilated by invertase-deficient yeast. He completed his invention.
【0008】すなわち、本発明は受容体の存在下、スク
ロースにフラクトシル基転移酵素およびインベルターゼ
欠損酵母を作用させることを特徴とするフラクトース含
有オリゴ糖または配糖体の製造方法を提供するものであ
る。That is, the present invention provides a method for producing fructose-containing oligosaccharides or glycosides, which is characterized by allowing fructosyltransferase and invertase-deficient yeast to act on sucrose in the presence of a receptor.
【0009】本発明では、フラクトシル基転移酵素がフ
ラクトース供与体(スクロース)に作用してグルコース
とフラクトースに加水分解し、生成したフラクトースを
受容体(キシロース,ガラクトース,ラクトースなど)
に転移させ、グルコースをインベルターゼ欠損酵母によ
って資化することにより、フラクトース含有オリゴ糖ま
たは配糖体を製造するものである。In the present invention, fructosyltransferase acts on a fructose donor (sucrose) to hydrolyze it into glucose and fructose, and the fructose produced is converted into an acceptor (xylose, galactose, lactose, etc.).
Fructose-containing oligosaccharides or glycosides are produced by transferring glucose to and assimilating glucose by invertase-deficient yeast.
【0010】本発明でいうフラクトース含有オリゴ糖と
は、キシロシルフラクトシド,ガラクトシルフラクトシ
ド,ラクトシルフラクトシド,ソルボシルフラクトシド
,フコシルフラクトシド,ケストース,スタキオース,
エルロース,ラフィノース,イソマルトシルフラクトシ
ド,キシロビオシルフラクトシドおよびアラビノシルフ
ラクトシドの中のいずれかを意味する。[0010] The fructose-containing oligosaccharides as used in the present invention include xylosylfructoside, galactosylfructoside, lactosylfructoside, sorbosylfructoside, fucosylfructoside, kestose, stachyose,
It means any one of erulose, raffinose, isomaltosylfructoside, xylobiosylfructoside, and arabinosylfructoside.
【0011】また、本発明でいうフラクトース含有配糖
体とは、フラクトシルステビオサイド,フラクトシルル
ブソサイドおよびフラクトシルレバウディオサイドの中
のいずれかを意味する。[0011] The term fructose-containing glycoside as used in the present invention means any one of fructosyl stevioside, fructosyl rubusoside and fructosyl rebaudioside.
【0012】フラクトース供与体から、フラクトシル基
転移酵素の酵素反応により生成するフラクトースを受容
する分子体としては、上記フラクトース含有オリゴ糖ま
たは配糖体を生成し得るものであればよい。具体的には
、例えばラクトース,キシロース,ガラクトースなどが
適している。The molecular entity that accepts fructose produced from the fructose donor by the enzymatic reaction of fructosyltransferase may be any one capable of producing the above fructose-containing oligosaccharide or glycoside. Specifically, for example, lactose, xylose, galactose, etc. are suitable.
【0013】受容体としてラクトースの代わりにキシロ
ースやガラクトースを用いた場合でも酵素反応は進行す
る(特開平3─27285号公報)。[0013] Even when xylose or galactose is used as a receptor instead of lactose, the enzymatic reaction proceeds (Japanese Unexamined Patent Publication No. 3-27285).
【0014】本発明で用いるフラクトシル基転移酵素は
、バチルス・ズブチリス(Bacillussubti
lis) 等の微生物が生産するレバンスクラーゼまた
はアルスロバクター・エスピー(Arthrobact
er sp.)等の微生物が生産するβ─フラクトフラ
ノシダーゼの中のいずれかであればよく、具体的にはバ
チルス・ズブチリス(Bacillus subtil
is) の生産するレバンシュクラーゼ、アスペルギル
ス・ニガー(Aspergillus niger),
ペニシリウム・オキザリクム(Penicillium
oxalicum), ペニシリウム・フリクエンタ
ンス(Penicillium frequentan
s),ペニシリウム・エスピー(Penicilliu
msp.) K25などのかびが生産するβ─フラクト
フラノシダーゼ、アルスロバクター・エスピー(Art
hrobacter sp.)K─1(特開平3─27
285号公報)の生産するβ─フラクトフラノシダーゼ
などである。[0014] The fructosyltransferase used in the present invention is Bacillus subtilis.
levansucrase produced by microorganisms such as Arthrobacter sp.
er sp. ), etc., and specifically, any β-fructofuranosidase produced by microorganisms such as Bacillus subtilis may be used.
is) levansucrase produced by Aspergillus niger,
Penicillium oxalicum
oxalicum), Penicillium frequentan
s), Penicilliu sp.
msp. ) β-Fructofuranosidase produced by molds such as K25, Arthrobacter sp.
hrobacter sp. ) K-1 (Unexamined Japanese Patent Publication No. 3-27
These include β-fructofuranosidase produced by No. 285).
【0015】上記フラクトシル基転移酵素の酵素反応で
生成したグルコースを資化するインベルターゼ欠損酵母
はキシロースを資化せず、さらにはグルコースの存在下
ではガラクトースも資化しないため、より一層酵素反応
を促進し、フラクトース含有オリゴ糖または配糖体を大
量に製造することができる。本発明に好適に使用するイ
ンベルターゼ欠損酵母としては、市販のものを用いるこ
とができる。例えばLS−Y(オリエンタル酵母工業株
式会社製)を挙げることができる。以下に、LS−Yの
特徴を示す。[0015] Invertase-deficient yeast, which assimilates glucose produced by the enzymatic reaction of fructosyltransferase, does not assimilate xylose, and furthermore, does not assimilate galactose in the presence of glucose, which further promotes the enzymatic reaction. However, fructose-containing oligosaccharides or glycosides can be produced in large quantities. As the invertase-deficient yeast suitably used in the present invention, commercially available yeasts can be used. For example, LS-Y (manufactured by Oriental Yeast Industry Co., Ltd.) can be mentioned. The characteristics of LS-Y are shown below.
【0016】
1)単糖類の資化性能
グルコースの資化性→720mgグルコース/h/g
wet yeast以上
2)スクロースの分解性
スクロースの資化性および発酵性→なしインベルターゼ
活性 0ユニット3)最適資化温度
30±2℃が最適で、この温度領域を超えると、資化活
性は著しく低下する。1) Monosaccharide assimilation ability Glucose assimilation ability → 720 mg glucose/h/g
wet yeast or higher 2) Degradability of sucrose Assimilation and fermentability of sucrose → None Invertase activity 0 units 3) Optimum assimilation temperature is optimal at 30 ± 2°C, and beyond this temperature range, assimilation activity decreases significantly. do.
【0017】目的とするフラクトース含有オリゴ糖また
は配糖体を生成させるためには、スクロース(フラクト
ース供与体)とフラクトース受容体とを共存せしめた基
質溶液に、フラクトシル基転移酵素およびインベルター
ゼ欠損酵母を作用させればよい。フラクトシル基転移酵
素およびインベルターゼ欠損酵母を作用させるにあたっ
ては、フラクトシル基転移酵素反応終了後、酵素を失活
した反応液にインベルターゼ欠損酵母を添加し作用させ
てもよいし、あるいはフラクトシル基転移酵素とインベ
ルターゼ欠損酵母を上記基質溶液に同時に添加して作用
させてもよい。In order to produce the desired fructose-containing oligosaccharide or glycoside, fructosyltransferase and invertase-deficient yeast are applied to a substrate solution in which sucrose (fructose donor) and fructose acceptor coexist. Just let it happen. When fructosyltransferase and invertase-deficient yeast are allowed to act, invertase-deficient yeast may be added to the reaction solution in which the enzyme has been deactivated after the fructosyltransferase reaction is completed, or the invertase-deficient yeast may be allowed to act on fructosyltransferase and invertase. The defective yeast may be added to the substrate solution at the same time and allowed to act.
【0018】具体的には、前者の場合には基質濃度は好
ましくは40%(w/w)とし、これにフラクトシル基
転移酵素を7.5〜10単位/gスクロース添加し、5
0℃〜60℃,pH6.5〜7.0にて9〜24時間反
応させた後、熱にて酵素を失活させる。次いで、インベ
ルターゼ欠損酵母を仕込み重量当たり2%以上添加し、
作用させる。このとき、反応温度は反応速度を考慮し3
0℃が好ましい。また、反応時のpHは3〜7の範囲内
であればかまわない。反応時間はインベルターゼ欠損酵
母添加量によって異なる。一方、後者の場合には基質濃
度は好ましくは30〜40%(w/w)とし、これにフ
ラクトシル基転移酵素を15〜40単位/gスクロース
添加し、インベルターゼ欠損酵母を仕込み重量当たり2
%以上添加して反応させる。反応時の温度は、酵素の至
適温度が35℃以上であれば35℃が良く、35℃未満
であれば酵素の至適温度が適当である。また、反応時の
pHは酵素の至適pHが3〜7であれば酵素の至適pH
が好ましく、その範囲から外れるものは酸性側であれば
pH3とし、アルカリ性側であればpH7とするのが好
ましい。反応時間は6〜30時間とすればよい。Specifically, in the former case, the substrate concentration is preferably 40% (w/w), 7.5 to 10 units/g sucrose of fructosyltransferase is added, and 5%
After reacting at 0° C. to 60° C. and pH 6.5 to 7.0 for 9 to 24 hours, the enzyme is inactivated by heat. Next, 2% or more of invertase-deficient yeast is added to the preparation weight,
Let it work. At this time, the reaction temperature is 3
0°C is preferred. Further, the pH during the reaction may be within the range of 3 to 7. The reaction time varies depending on the amount of invertase-deficient yeast added. On the other hand, in the latter case, the substrate concentration is preferably 30 to 40% (w/w), 15 to 40 units of fructosyltransferase/g of sucrose is added, and invertase-deficient yeast is prepared at a rate of 2.
% or more and react. The temperature during the reaction is preferably 35°C if the optimum temperature of the enzyme is 35°C or higher, and the optimum temperature of the enzyme is suitable if it is below 35°C. In addition, the pH during the reaction should be the optimum pH of the enzyme if the optimum pH of the enzyme is 3 to 7.
is preferable, and for those outside this range, it is preferable to set the pH to 3 if it is on the acidic side, and to set it to pH 7 if it is on the alkaline side. The reaction time may be 6 to 30 hours.
【0019】このようにして得られたフラクトース含有
オリゴ糖または配糖体を含む反応液は、硅藻土ろ過など
の方法によりインベルターゼ欠損酵母を除去した後、酵
素を加熱失活させ、活性炭脱色,イオン交換樹脂を用い
て脱塩,脱色し、さらに活性炭カラムクトマトグラフィ
ーなどのクロマト操作により高純度に精製して目的とす
るフラクトース含有オリゴ糖または配糖体を得ることが
できる。The thus obtained reaction solution containing fructose-containing oligosaccharides or glycosides is subjected to diatomaceous earth filtration to remove invertase-deficient yeast, the enzyme is inactivated by heating, and activated carbon decolorization is carried out. The desired fructose-containing oligosaccharide or glycoside can be obtained by desalting and decolorizing using an ion exchange resin, and further purifying to a high degree of purity by chromatography such as activated carbon column chromatography.
【0020】また、本発明では基質溶液中のスクロース
と受容体の比率を変えることによって、粉末品および液
状品に適した糖組成に調整できる。例えば製品のスクロ
ース含量が高い場合は粉末化が困難であるため、基質溶
液中のスクロース含量を抑えるようにスクロースと受容
体の比率を変えればよく、一方製品のラクトース(受容
体)の含量が高い液状の場合は、ラクトースの結晶が析
出してくるので基質溶液中のラクトース含量を抑えるよ
うにスクロースと受容体の比率を変えればよい。Furthermore, in the present invention, by changing the ratio of sucrose and acceptor in the substrate solution, the sugar composition can be adjusted to be suitable for powdered products and liquid products. For example, if the product has a high sucrose content, it will be difficult to powder it, so the ratio of sucrose to acceptor can be changed to reduce the sucrose content in the substrate solution, whereas if the product has a high lactose (acceptor) content, it will be difficult to powder it. If it is in liquid form, lactose crystals will precipitate, so the ratio of sucrose to acceptor may be changed to suppress the lactose content in the substrate solution.
【0021】[0021]
【実施例】次に、本発明を実施例により説明する。[Example] Next, the present invention will be explained with reference to an example.
【0022】実施例1
ラクトシルフラクトシド(以下、LSと略記する。)製
造におけるインベルターゼ欠損酵母 LS−Y(オリ
エンタル酵母工業株式会社製)添加の影響を検討した。
試験方法は以下に示す通りである。LS−Yを添加しな
い方法では、スクロース50.0g,ラクトース51.
6gを最終濃度40%(w/w)になるように溶解し、
アルスロバクター・エスピー(Arthrobacte
r sp.)K─1の生産するβ─フラクトフラノシダ
ーゼ(以下、K−1酵素と略記する。)をスクロース重
量(g)当たり7.5単位添加し、pH6.5,温度5
5℃で20時間反応させた。一方、LS−Yを添加した
方法では、スクロース50.0g,ラクトース51.6
gを最終濃度30%(w/w)になるように溶解し、K
−1酵素をスクロース重量(g)当たり25単位添加し
、同時にLS−Yを仕込み重量の3%添加してpH6.
5〜7.0,温度35℃で20時間反応させた。ここで
、酵素活性は1分間に1μmol のフラクトースを転
移する酵素量を1単位とした。LS生成量の経時変化を
図2に示す。なお、LS生成量は高速液体クロマトグラ
フィー(HPLC)を用いて測定した。以下の実施例に
ついても同様である。HPLCの条件を以下に示す。Example 1 The effect of adding invertase-deficient yeast LS-Y (manufactured by Oriental Yeast Co., Ltd.) on the production of lactosyl fructoside (hereinafter abbreviated as LS) was investigated. The test method is as shown below. In the method without adding LS-Y, 50.0 g of sucrose and 51.0 g of lactose were added.
Dissolve 6g to a final concentration of 40% (w/w),
Arthrobacter sp.
r sp. ) 7.5 units of β-fructofuranosidase produced by K-1 (hereinafter abbreviated as K-1 enzyme) per sucrose weight (g), pH 6.5, temperature 5
The reaction was carried out at 5°C for 20 hours. On the other hand, in the method adding LS-Y, sucrose 50.0g, lactose 51.6g
Dissolve K to a final concentration of 30% (w/w), and
-1 enzyme was added at 25 units per sucrose weight (g), and at the same time, LS-Y was added in an amount of 3% of the preparation weight to pH 6.
5 to 7.0, and the reaction was carried out at a temperature of 35°C for 20 hours. Here, one unit of enzyme activity was defined as the amount of enzyme that transferred 1 μmol of fructose per minute. Figure 2 shows the change over time in the amount of LS produced. Note that the amount of LS produced was measured using high performance liquid chromatography (HPLC). The same applies to the following examples. The HPLC conditions are shown below.
【0023】カラム:TOSOH TSK−GEL
Amide−80
移動相:70%アセトニトリル
流速 :1ml/min
温度 :35℃
検出器:示差屈折計Column: TOSOH TSK-GEL
Amide-80 Mobile phase: 70% acetonitrile Flow rate: 1 ml/min Temperature: 35°C Detector: Differential refractometer
【0024】図2より明らかなように、基質濃度,酵素
添加量,反応温度が異なるものの、LS−Yを用いた場
合には明らかに酵素の反応平衡がくずれ、LSの増収が
確認できる。As is clear from FIG. 2, although the substrate concentration, the amount of enzyme added, and the reaction temperature are different, when LS-Y is used, the reaction equilibrium of the enzyme is clearly disrupted, and an increase in the yield of LS can be confirmed.
【0025】実施例2
スクロース15kg,ラクトース15kgを最終濃度4
0%(w/w)になるように水道水に溶解し、K−1酵
素をスクロース重量(g)当たり7.5単位添加し、p
H6.5,温度50℃で18時間反応させた。次いで、
温度を30℃に冷却し、濃度を30%(w/w)に希釈
し、LS−Yを仕込み重量の5%になるように添加し、
30℃で18時間反応させた。反応終了後、LS−Yを
硅藻土ろ過により除去し、95℃で1時間活性炭処理後
、イオン交換樹脂(IRA−400,IR−120B)
で精製した。これを濃縮後、スプレードライして22.
5kgの粉末品を得た。転移反応時,酵母反応時および
粉末品の糖組成を表1に示す。Example 2 15 kg of sucrose and 15 kg of lactose were added to a final concentration of 4.
0% (w/w) in tap water, and added 7.5 units of K-1 enzyme per sucrose weight (g).
The reaction was carried out at H6.5 and a temperature of 50° C. for 18 hours. Then,
The temperature was cooled to 30 °C, the concentration was diluted to 30% (w/w), and LS-Y was added to 5% of the weight of the preparation.
The reaction was carried out at 30°C for 18 hours. After the reaction, LS-Y was removed by diatomaceous earth filtration, treated with activated carbon at 95°C for 1 hour, and then treated with ion exchange resin (IRA-400, IR-120B).
It was purified with After concentrating this, spray dry it.22.
5 kg of powder product was obtained. Table 1 shows the sugar composition during the transfer reaction, during the yeast reaction, and in the powdered product.
【0026】
表1─────
─────────────────────────
────── 糖組成
単糖 スクロース ラクトース
LS ──────────────────
────────────────── 転移反
応時 17.0 23.0
26.0 34.0 酵母反応時
── 31.3
31.3 41.0 粉末品
2.0 26.1
32.3 39.6───────────
─────────────────────────
*表中の数値は固形分中の含量(%)を表す。Table 1──────
──────────────────────────
────── Sugar composition
Monosaccharide sucrose lactose
LS ──────────────────
────────────────── At the time of transfer reaction 17.0 23.0
26.0 34.0 During yeast reaction
──31.3
31.3 41.0 Powder products
2.0 26.1
32.3 39.6────────────
──────────────────────────
*The numbers in the table represent the content (%) in solid content.
【0027】実施例3
スクロースおよびラクトースを0.1Mリン酸緩衝液(
pH6.5)に最終濃度が40%(w/w)になるよう
に等量混合溶解し、K−1酵素をスクロース重量(g)
当たり40単位添加し、同時にLS−Yを仕込み重量の
2%添加して30℃で72時間反応させた。糖組成の経
時変化を図3に示す。Example 3 Sucrose and lactose were dissolved in 0.1M phosphate buffer (
K-1 enzyme was mixed and dissolved in equal amounts to a final concentration of 40% (w/w) (pH 6.5), and the K-1 enzyme was dissolved in sucrose weight (g).
At the same time, LS-Y was added in an amount of 2% of the charged weight, and the reaction was carried out at 30° C. for 72 hours. Figure 3 shows the change in sugar composition over time.
【0028】図3より明らかなように、酵素と同時にL
S−Yを作用させると、酵素の反応平衡がくずれLSが
増収される。また、糖中のLSの含量も65%と高いも
のであった。As is clear from FIG. 3, L
When SY acts, the reaction equilibrium of the enzyme is disrupted and the yield of LS is increased. Furthermore, the content of LS in the sugar was as high as 65%.
【0029】実施例4
スクロース45.0g,ラクトース56.8gを最終濃
度30%(w/w)になるように水道水に溶解し、K−
1酵素をスクロース重量(g)当たり15単位になるよ
うに添加し、同時にLS−Yを仕込み重量の3%添加し
た。温度35℃で28時間反応させた。pHは6.5〜
7.0の範囲に入るようにNaOHを用いて調整した。
糖組成の経時変化を図4に示す。Example 4 45.0 g of sucrose and 56.8 g of lactose were dissolved in tap water to a final concentration of 30% (w/w).
1 enzyme was added in an amount of 15 units per sucrose weight (g), and at the same time, LS-Y was added in an amount of 3% of the weight of the preparation. The reaction was carried out at a temperature of 35°C for 28 hours. pH is 6.5~
It was adjusted using NaOH to fall within the range of 7.0. Figure 4 shows the change in sugar composition over time.
【0030】図4より明らかなように、K−1酵素の量
はスクロース重量(g)当たり15単位で十分なもので
あることがわかった。As is clear from FIG. 4, it was found that an amount of K-1 enzyme of 15 units per sucrose weight (g) was sufficient.
【0031】実施例5
スクロース(水分0.03%)1500kg,ラクトー
ス(水分3.1%)1850Kgを最終濃度30%(w
/w)になるように水道水に溶解し、K−1酵素をスク
ロース重量(g)当たり25単位になるように添加し、
同時にLS−Yを仕込み重量の3%添加した。温度35
℃で、pHは6.5〜7.0の範囲に入るようにNaO
Hを用いて調整して反応させた。反応22時間後、仕込
み重量の1%に相当する活性炭を添加して常温にて硅藻
土ろ過を行い、LS−Yを除去した。次いで、活性炭を
仕込み重量の2%添加し95℃に30分間保った後、7
0℃に冷却してから再び硅藻土ろ過を行った。さらに、
35℃に冷却してイオン交換樹脂で脱塩脱色を行った。
これをエバポレータで濃度55%(w/w)に濃縮し、
スプレードライにて2360kgの粉末品を得た。得ら
れた粉末品の糖組成を表2に示す。Example 5 1500 kg of sucrose (water content 0.03%) and 1850 kg of lactose (water content 3.1%) were mixed at a final concentration of 30% (w).
/w) in tap water, and added K-1 enzyme to 25 units per sucrose weight (g).
At the same time, 3% of the weight of LS-Y was added. temperature 35
℃, the pH was in the range of 6.5-7.0 with NaO
The mixture was adjusted using H and reacted. After 22 hours of reaction, activated carbon corresponding to 1% of the charged weight was added, and diatomaceous earth filtration was performed at room temperature to remove LS-Y. Next, activated carbon was added in an amount of 2% of the weight of the preparation and kept at 95°C for 30 minutes.
After cooling to 0°C, diatomaceous earth filtration was performed again. moreover,
The mixture was cooled to 35° C. and desalted and decolorized using an ion exchange resin. Concentrate this to a concentration of 55% (w/w) using an evaporator,
A powder product weighing 2360 kg was obtained by spray drying. The sugar composition of the obtained powder product is shown in Table 2.
【0032】
表2───
─────────────────────────
──────── 糖組成
単糖 スクロース ラクトース
LS ────────────────
────────────────────
粉末品 3.5 7.
1 22.0 57.5────
─────────────────────────
───────*表中の数値は固形分中の含量(%)を
表す。Table 2----
──────────────────────────
──────── Sugar composition
Monosaccharide sucrose lactose
LS ────────────────
────────────────────
Powder product 3.5 7.
1 22.0 57.5────
──────────────────────────
────────*The numbers in the table represent the content (%) in solid content.
【0033】[0033]
【発明の効果】本発明によれば、低コストで効率よくフ
ラクトース含有オリゴ糖または配糖体を工業的に製造す
ることができる。本発明により得られるフラクトース含
有オリゴ糖または配糖体は、抗う蝕性,ビフィズス菌増
殖活性を有するので、医薬品や食品の分野で有用である
。According to the present invention, fructose-containing oligosaccharides or glycosides can be industrially produced efficiently at low cost. The fructose-containing oligosaccharides or glycosides obtained according to the present invention have anti-cariogenic properties and bifidobacterial growth activity, and are therefore useful in the fields of pharmaceuticals and foods.
【0034】[0034]
【図1】 ラクトシルフラクトシドの構造を示すもの
である。FIG. 1 shows the structure of lactosyl fructoside.
【図2】 実施例1におけるLS生成量の経時変化を
示すものである。FIG. 2 shows changes over time in the amount of LS produced in Example 1.
【図3】 実施例3における糖組成の経時変化を示す
ものである。FIG. 3 shows changes in sugar composition over time in Example 3.
【図4】 実施例4における糖組成の経時変化を示す
ものである。FIG. 4 shows changes in sugar composition over time in Example 4.
Claims (4)
トシル基転移酵素およびインベルターゼ欠損酵母を作用
させることを特徴とするフラクトース含有オリゴ糖また
は配糖体の製造方法。1. A method for producing fructose-containing oligosaccharides or glycosides, which comprises allowing fructosyltransferase and invertase-deficient yeast to act on sucrose in the presence of a receptor.
ルフラクトシド,ガラクトシルフラクトシド,ラクトシ
ルフラクトシド,ソルボシルフラクトシド,フコシルフ
ラクトシド,ケストース,スタキオース,エルロース,
ラフィノース,イソマルトシルフラクトシド,キシロビ
オシルフラクトシドおよびアラビノシルフラクトシドの
中のいずれかである請求項1記載のフラクトース含有オ
リゴ糖の製造方法。[Claim 2] The fructose-containing oligosaccharide is xylosylfructoside, galactosylfructoside, lactosylfructoside, sorbosylfructoside, fucosylfructoside, kestose, stachyose, erulose,
2. The method for producing a fructose-containing oligosaccharide according to claim 1, which is any one of raffinose, isomaltosylfructoside, xylobiosylfructoside, and arabinosylfructoside.
ルステビオサイド,フラクトシルルブソサイドおよびフ
ラクトシルレバウディオサイドの中のいずれかである請
求項1記載のフラクトース含有配糖体の製造方法。3. The method for producing a fructose-containing glycoside according to claim 1, wherein the fructose-containing glycoside is any one of fructosyl stevioside, fructosyl rubusoside and fructosyl rebaudioside.
ズブチリス(Bacillussubtilis) 等
の微生物が生産するレバンスクラーゼまたはアルスロバ
クター・エスピー(Arthrobacter sp.
)等の微生物が生産するβ─フラクトフラノシダーゼの
中のいずれかである請求項1記載のフラクトース含有オ
リゴ糖または配糖体の製造方法。Claim 4: The fructosyltransferase is Bacillus.
levansucrase produced by microorganisms such as Bacillus subtilis or Arthrobacter sp.
2. The method for producing a fructose-containing oligosaccharide or glycoside according to claim 1, wherein the fructose-containing oligosaccharide or glycoside is any one of β-fructofuranosidases produced by microorganisms such as ).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3081337A JPH04293494A (en) | 1991-03-22 | 1991-03-22 | Production of fructose-containing oligosaccharide or glycoside |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3081337A JPH04293494A (en) | 1991-03-22 | 1991-03-22 | Production of fructose-containing oligosaccharide or glycoside |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH04293494A true JPH04293494A (en) | 1992-10-19 |
Family
ID=13743559
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP3081337A Pending JPH04293494A (en) | 1991-03-22 | 1991-03-22 | Production of fructose-containing oligosaccharide or glycoside |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH04293494A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100337144B1 (en) * | 2000-01-26 | 2002-05-18 | 서진호 | Process for the preparation of kimchi producing oligosaccharide and fructose |
WO2006011301A1 (en) * | 2004-07-29 | 2006-02-02 | Ensuiko Sugar Refining Co., Ltd. | Crystalline lactosucrose or molasses-containing crystal having the same contained therein, and use thereof |
KR20190047624A (en) * | 2017-10-27 | 2019-05-08 | 씨제이제일제당 (주) | A method of manufacturing fructosyl steviol glycosides using the Arthrobacter sp. microorganism |
KR20210111721A (en) * | 2019-04-19 | 2021-09-13 | 씨제이제일제당 (주) | Composition comprising transfructosylated steviol glycoside |
WO2023031625A1 (en) * | 2021-09-03 | 2023-03-09 | Optibiotix Limited | Sweetener compositions and methods of production thereof |
-
1991
- 1991-03-22 JP JP3081337A patent/JPH04293494A/en active Pending
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100337144B1 (en) * | 2000-01-26 | 2002-05-18 | 서진호 | Process for the preparation of kimchi producing oligosaccharide and fructose |
WO2006011301A1 (en) * | 2004-07-29 | 2006-02-02 | Ensuiko Sugar Refining Co., Ltd. | Crystalline lactosucrose or molasses-containing crystal having the same contained therein, and use thereof |
KR20190047624A (en) * | 2017-10-27 | 2019-05-08 | 씨제이제일제당 (주) | A method of manufacturing fructosyl steviol glycosides using the Arthrobacter sp. microorganism |
WO2019083309A3 (en) * | 2017-10-27 | 2019-06-27 | 씨제이제일제당 (주) | Method for preparing transfructosylated stevioside using arthrobacter genus microorganisms |
CN111511909A (en) * | 2017-10-27 | 2020-08-07 | Cj第一制糖株式会社 | Method for preparing transfructosyl stevioside by using microorganism of arthrobacter |
US11332770B2 (en) | 2017-10-27 | 2022-05-17 | Cj Cheiljedang Corporation | Method for preparing transfructosylated steviol glycoside using microorganism of genus arthrobacter |
KR20210111721A (en) * | 2019-04-19 | 2021-09-13 | 씨제이제일제당 (주) | Composition comprising transfructosylated steviol glycoside |
WO2023031625A1 (en) * | 2021-09-03 | 2023-03-09 | Optibiotix Limited | Sweetener compositions and methods of production thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5935636A (en) | Trehalose and its production and use | |
Monsan et al. | Enzymatic synthesis of oligosaccharides | |
KR100291757B1 (en) | Non-Reducing Glycose Generating Enzyme, Method of Use, and Use thereof | |
EP0636632B1 (en) | Non-reducing oligosaccharides and their production and use | |
JP4983258B2 (en) | Isocyclomalto-oligosaccharides and isocyclomalto-oligosaccharide-producing enzymes, their production methods and uses | |
US5919668A (en) | Non-reducing saccharide and its production and use | |
WO2005021564A1 (en) | Cyclic maltosyl maltose, cyclic maltosyl maltose synthase, method of producing the same and use thereof | |
KR960006579B1 (en) | Processing method of oligosaccharide | |
EP0690131B1 (en) | Non-reducing saccharide and its production and use | |
JP2952439B2 (en) | New food and drink ingredients | |
JPH04293494A (en) | Production of fructose-containing oligosaccharide or glycoside | |
EP0670327B1 (en) | Crystalline maltotetraosyl glucoside, and its production and use | |
US5576303A (en) | Energy-supplementing saccharide source and its uses | |
JPH0710898A (en) | Method for modifying sparingly water-soluble flavonoid | |
US5912330A (en) | Crystalline maltosyl glucoside, and its production and use | |
JPH035788B2 (en) | ||
JP2832037B2 (en) | Food material | |
JP2750374B2 (en) | Novel production method of β-glucooligosaccharide by oxygen method | |
JPH0349693A (en) | Production of n-acetyllactosamine | |
US5908767A (en) | Non-reducing saccharide and its production and use | |
JP7441178B2 (en) | Cycloisomaltotetraose, cycloisomaltotetraose-generating enzymes, their production methods and uses | |
JP2860489B2 (en) | Food material, bifidobacterium growth promoter and method for producing them | |
JP2927845B2 (en) | Oligosaccharide composition and method for producing the same | |
KR960003643B1 (en) | Preparation process of galacto oligosaccharide | |
JP2899619B2 (en) | Novel food material containing isomaltosyl fructoside and / or isomeletitose |